Is SILA undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6
Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of SILA when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: SILA ($25.45) is trading below our estimate of fair value ($70.23)
Significantly Below Fair Value: SILA is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for SILA?
Key metric: As SILA is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
The above table shows the Price to Earnings ratio for SILA. This is calculated by dividing SILA's market cap by their current
earnings.
What is SILA's PE Ratio?
PE Ratio
62.1x
Earnings
US$22.55m
Market Cap
US$1.40b
SILA key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Price-To-Earnings vs Industry: SILA is expensive based on its Price-To-Earnings Ratio (62.1x) compared to the Global Health Care REITs industry average (26.7x).
Price to Earnings Ratio vs Fair Ratio
What is SILA's PE Ratio
compared to its
Fair PE Ratio?
This is the expected PE Ratio taking into
account the company's forecast earnings growth, profit margins
and other risk factors.
SILA PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio
62.1x
Fair PE Ratio
50.1x
Price-To-Earnings vs Fair Ratio: SILA is expensive based on its Price-To-Earnings Ratio (62.1x) compared to the estimated Fair Price-To-Earnings Ratio (50.1x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Target price is less than 20% higher than the current share price.